» Articles » PMID: 11796255

Alzheimer's and Parkinson's Disease--overlapping or Synergistic Pathologies?

Overview
Journal Trends Mol Med
Date 2002 Feb 14
PMID 11796255
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) and Parkinson's disease (PD) are the two most common neurodegenerative disorders in humans. They are characterized by insoluble protein deposits; beta-amyloid plaques and tau-containing neurofibrillary lesions in AD, and alpha-synuclein-containing Lewy bodies in PD. As a significant percentage of patients have clinical and pathological features of both diseases, the patho-cascades of the two diseases might overlap. For the first time, new animal models that express multiple transgenes provide the tools to dissect the pathogenic pathways and to differentiate between additive and synergistic effects.

Citing Articles

Liposomes as versatile agents for the management of traumatic and nontraumatic central nervous system disorders: drug stability, targeting efficiency, and safety.

Zhang M, Xiang C, Niu R, He X, Luo W, Liu W Neural Regen Res. 2024; 20(7):1883-1899.

PMID: 39254548 PMC: 11691476. DOI: 10.4103/NRR.NRR-D-24-00048.


Proteomic-Based Studies on Memory Formation in Normal and Neurodegenerative Disease-Affected Brains.

da Silva Beraldo I, Prates Rodrigues M, Polanczyk R, Verano-Braga T, Lopes-Aguiar C Adv Exp Med Biol. 2024; 1443:129-158.

PMID: 38409419 DOI: 10.1007/978-3-031-50624-6_7.


Nigrostriatal tau pathology in parkinsonism and Parkinson's disease.

Chu Y, Hirst W, Federoff H, Harms A, Stoessl A, Kordower J Brain. 2023; 147(2):444-457.

PMID: 38006313 PMC: 10834249. DOI: 10.1093/brain/awad388.


Extracellular Vesicles, Cell-Penetrating Peptides and miRNAs as Future Novel Therapeutic Interventions for Parkinson's and Alzheimer's Disease.

Keighron C, Avazzadeh S, Goljanek-Whysall K, McDonagh B, Howard L, Ritter T Biomedicines. 2023; 11(3).

PMID: 36979707 PMC: 10045119. DOI: 10.3390/biomedicines11030728.


Curcumin inhibits APOE4-induced injury by activating peroxisome proliferator-activated receptor-γ (PPARγ) in SH-SY5Y cells.

Wang M, Kou J, Wang C, Yu X, Xie X, Pang X Iran J Basic Med Sci. 2021; 23(12):1576-1583.

PMID: 33489032 PMC: 7811813. DOI: 10.22038/ijbms.2020.47184.10858.